CN Stock MarketDetailed Quotes

300463 Maccura Biotechnology

Watchlist
  • 14.21
  • -0.39-2.67%
Market Closed Dec 13 15:00 CST
8.70BMarket Cap26.76P/E (TTM)

Maccura Biotechnology Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-7.92%1.95B
-7.37%1.28B
-8.88%616.37M
-19.75%2.9B
-22.19%2.12B
-22.51%1.38B
-26.85%676.4M
-9.35%3.61B
-9.67%2.72B
-9.11%1.78B
Operating revenue
-7.92%1.95B
-7.37%1.28B
-8.88%616.37M
-19.75%2.9B
-22.19%2.12B
-22.51%1.38B
-26.85%676.4M
-9.35%3.61B
-9.67%2.72B
-9.11%1.78B
Other operating revenue
----
-30.95%12.64M
----
-15.50%33.95M
----
-8.67%18.31M
----
-13.54%40.18M
----
5.01%20.05M
Total operating cost
-6.15%1.64B
-6.10%1.08B
-9.25%483.29M
-9.30%2.51B
-13.19%1.75B
-11.49%1.15B
-18.55%532.54M
-0.58%2.76B
1.11%2.02B
1.60%1.3B
Operating cost
-12.54%833.71M
-14.57%549.93M
-13.13%262.5M
-21.58%1.3B
-25.72%953.2M
-20.88%643.7M
-28.35%302.17M
-1.32%1.65B
2.34%1.28B
-0.96%813.53M
Operating tax surcharges
-6.50%15.9M
-2.64%11.85M
-10.33%4.03M
-21.40%27.14M
-28.14%17.01M
-30.77%12.17M
-36.51%4.5M
-3.03%34.53M
-6.55%23.67M
0.32%17.58M
Operating expense
2.07%437.35M
0.41%287.66M
-5.49%120.71M
3.58%652.41M
-0.05%428.47M
1.86%286.48M
-5.50%127.73M
-1.03%629.87M
1.30%428.66M
9.00%281.26M
Administration expense
-0.12%117.4M
11.05%77.03M
-2.63%32.69M
18.27%184.23M
16.35%117.54M
7.12%69.37M
-7.82%33.57M
-7.50%155.77M
2.39%101.02M
2.37%64.76M
Financial expense
-10.89%14.53M
-8.73%7.44M
-38.48%3.83M
27.46%23.31M
36.61%16.31M
-49.21%8.15M
-12.27%6.22M
-68.40%18.29M
-72.48%11.94M
-45.39%16.04M
-Interest expense (Financial expense)
-38.57%15.14M
-24.52%11.68M
-2.39%5.95M
-4.34%33.53M
-10.77%24.64M
-18.69%15.47M
-44.57%6.09M
-40.86%35.06M
-39.32%27.62M
-35.19%19.02M
-Interest Income (Financial expense)
44.95%-4.21M
26.70%-3.6M
10.43%-1.84M
16.45%-10.03M
20.64%-7.65M
31.23%-4.91M
59.91%-2.05M
-139.88%-12.01M
-153.26%-9.65M
-175.87%-7.14M
Research and development
2.73%223.1M
12.39%144.5M
2.02%59.52M
18.65%324.17M
30.17%217.17M
23.17%128.57M
25.80%58.35M
31.82%273.22M
12.14%166.83M
19.38%104.39M
Credit Impairment Loss
147.53%9.06M
934.00%14.05M
-280.58%-4.86M
-6.38%-36.37M
7.13%-19.07M
86.10%-1.68M
90.36%-1.28M
-254.60%-34.19M
-92.82%-20.54M
-22.82%-12.12M
Asset Impairment Loss
87.07%-7.03M
93.05%-3.44M
98.15%-93.68K
-142.09%-58.04M
-534.05%-54.33M
-267.39%-49.42M
44.50%-5.06M
-35.95%-23.97M
-31.55%-8.57M
-117.01%-13.45M
Other net revenue
121.78%12.93M
153.63%23.53M
194.88%3.36M
-110.55%-58.05M
-222.89%-59.34M
-253.14%-43.87M
82.56%-3.55M
-313.01%-27.57M
-2,625.03%-18.38M
-77.15%-12.42M
Fair value change income
43.68%-8.67M
74.48%-2.22M
78.08%-1.58M
22.27%-7.08M
-12.66%-15.39M
-856.58%-8.7M
---7.22M
---9.1M
---13.66M
---909.8K
Invest income
-65.80%3.39M
-66.51%2.65M
-51.15%1.85M
-29.25%8.59M
-21.22%9.92M
30.42%7.9M
--3.79M
2,974.97%12.15M
2,539.81%12.59M
1,274.20%6.06M
-Including: Investment income associates
----
----
--0
-87.86%42.22K
-54.90%202.21K
-10.90%202.21K
--138.32K
-11.92%347.88K
186.87%448.36K
143.97%226.96K
Asset deal income
-84.03%-5.8M
-22.66%-3.43M
-258.71%-1.38M
-1.13%-4.17M
6.14%-3.15M
-0.15%-2.8M
-100.06%-386.04K
-1.74%-4.12M
-185.49%-3.36M
-404.96%-2.79M
Other revenue
-3.18%21.96M
47.10%15.92M
42.86%9.44M
23.17%39.01M
49.69%22.68M
0.36%10.82M
196.88%6.61M
-27.80%31.67M
4.62%15.15M
6.58%10.79M
Operating profit
4.08%318.54M
18.91%224.04M
-2.75%136.45M
-59.49%331.14M
-55.29%306.05M
-60.07%188.41M
-43.99%140.31M
-32.67%817.39M
-32.68%684.47M
-30.23%471.83M
Add:Non operating Income
333.08%1.41M
919.61%1.37M
31.79%73.57K
-5.41%378.13K
-4.95%326.02K
196.18%134.75K
420.57%55.82K
-28.51%399.73K
31.02%343.01K
-65.61%45.49K
Less:Non operating expense
-19.47%8.67M
-62.33%2.27M
-89.95%535.22K
-8.91%26.15M
-20.71%10.77M
28.69%6.04M
192.72%5.32M
4.41%28.71M
356.79%13.58M
126.86%4.69M
Total profit
5.30%311.28M
22.26%223.14M
0.70%135.98M
-61.30%305.37M
-55.96%295.6M
-60.93%182.51M
-45.71%135.04M
-33.53%789.08M
-33.80%671.23M
-30.72%467.18M
Less:Income tax cost
2.23%28.19M
91.53%20.65M
-31.81%11.74M
-99.21%689.9K
-61.09%27.57M
-81.15%10.78M
-52.88%17.22M
-52.74%87.38M
-60.84%70.86M
-51.23%57.2M
Net profit
5.62%283.1M
17.91%202.49M
5.45%124.24M
-56.58%304.68M
-55.36%268.03M
-58.11%171.73M
-44.47%117.83M
-29.99%701.71M
-27.93%600.37M
-26.40%409.98M
Net profit from continuing operation
5.62%283.1M
17.91%202.49M
5.45%124.24M
-56.58%304.68M
-55.36%268.03M
-58.11%171.73M
-44.47%117.83M
-29.99%701.71M
-27.93%600.37M
-26.40%409.98M
Less:Minority Profit
367.30%1.72M
124.57%764.15K
299.05%3.8M
-22.61%-7.94M
-147.77%-645.21K
-173.86%-3.11M
-90.79%952.67K
-114.19%-6.48M
-100.70%-260.41K
-83.41%4.21M
Net profit of parent company owners
4.72%281.37M
15.38%201.73M
3.05%120.44M
-55.86%312.62M
-55.27%268.68M
-56.91%174.84M
-42.10%116.87M
-25.97%708.18M
-24.56%600.64M
-23.68%405.77M
Earning per share
Basic earning per share
5.65%0.4635
16.29%0.332
5.26%0.2
-56.20%0.5136
-55.72%0.4387
-57.57%0.2855
-44.10%0.19
-32.25%1.1726
-30.85%0.9907
-29.65%0.6728
Diluted earning per share
4.72%0.4594
15.38%0.3294
5.26%0.2
-56.19%0.5104
-55.72%0.4387
-57.57%0.2855
-44.10%0.19
-32.18%1.1651
-30.70%0.9907
-29.53%0.6728
Other composite income
46.52%-9.04M
86.27%-1.25M
95.64%-363.65K
-152.74%-8.4M
-215.51%-16.91M
-129.41%-9.12M
-8.33M
472.55%15.93M
14.64M
31.03M
Other composite income of parent company owners
46.52%-9.04M
86.27%-1.25M
95.64%-363.65K
-152.74%-8.4M
-215.51%-16.91M
-129.41%-9.12M
---8.33M
472.55%15.93M
--14.64M
--31.03M
Total composite income
9.13%274.05M
23.76%201.24M
13.14%123.88M
-58.71%296.28M
-59.17%251.12M
-63.13%162.6M
-48.40%109.49M
-28.09%717.63M
-26.18%615.01M
-20.83%441.01M
Total composite income of parent company owners
8.17%272.33M
20.98%200.47M
10.63%120.08M
-57.99%304.22M
-59.08%251.77M
-62.06%165.71M
-46.23%108.54M
-23.96%724.11M
-22.72%615.27M
-17.85%436.8M
Total composite income of minority owners
367.30%1.72M
124.57%764.15K
299.05%3.8M
-22.61%-7.94M
-147.77%-645.21K
-173.86%-3.11M
-90.79%952.67K
-114.19%-6.48M
-100.70%-260.41K
-83.41%4.21M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -7.92%1.95B-7.37%1.28B-8.88%616.37M-19.75%2.9B-22.19%2.12B-22.51%1.38B-26.85%676.4M-9.35%3.61B-9.67%2.72B-9.11%1.78B
Operating revenue -7.92%1.95B-7.37%1.28B-8.88%616.37M-19.75%2.9B-22.19%2.12B-22.51%1.38B-26.85%676.4M-9.35%3.61B-9.67%2.72B-9.11%1.78B
Other operating revenue -----30.95%12.64M-----15.50%33.95M-----8.67%18.31M-----13.54%40.18M----5.01%20.05M
Total operating cost -6.15%1.64B-6.10%1.08B-9.25%483.29M-9.30%2.51B-13.19%1.75B-11.49%1.15B-18.55%532.54M-0.58%2.76B1.11%2.02B1.60%1.3B
Operating cost -12.54%833.71M-14.57%549.93M-13.13%262.5M-21.58%1.3B-25.72%953.2M-20.88%643.7M-28.35%302.17M-1.32%1.65B2.34%1.28B-0.96%813.53M
Operating tax surcharges -6.50%15.9M-2.64%11.85M-10.33%4.03M-21.40%27.14M-28.14%17.01M-30.77%12.17M-36.51%4.5M-3.03%34.53M-6.55%23.67M0.32%17.58M
Operating expense 2.07%437.35M0.41%287.66M-5.49%120.71M3.58%652.41M-0.05%428.47M1.86%286.48M-5.50%127.73M-1.03%629.87M1.30%428.66M9.00%281.26M
Administration expense -0.12%117.4M11.05%77.03M-2.63%32.69M18.27%184.23M16.35%117.54M7.12%69.37M-7.82%33.57M-7.50%155.77M2.39%101.02M2.37%64.76M
Financial expense -10.89%14.53M-8.73%7.44M-38.48%3.83M27.46%23.31M36.61%16.31M-49.21%8.15M-12.27%6.22M-68.40%18.29M-72.48%11.94M-45.39%16.04M
-Interest expense (Financial expense) -38.57%15.14M-24.52%11.68M-2.39%5.95M-4.34%33.53M-10.77%24.64M-18.69%15.47M-44.57%6.09M-40.86%35.06M-39.32%27.62M-35.19%19.02M
-Interest Income (Financial expense) 44.95%-4.21M26.70%-3.6M10.43%-1.84M16.45%-10.03M20.64%-7.65M31.23%-4.91M59.91%-2.05M-139.88%-12.01M-153.26%-9.65M-175.87%-7.14M
Research and development 2.73%223.1M12.39%144.5M2.02%59.52M18.65%324.17M30.17%217.17M23.17%128.57M25.80%58.35M31.82%273.22M12.14%166.83M19.38%104.39M
Credit Impairment Loss 147.53%9.06M934.00%14.05M-280.58%-4.86M-6.38%-36.37M7.13%-19.07M86.10%-1.68M90.36%-1.28M-254.60%-34.19M-92.82%-20.54M-22.82%-12.12M
Asset Impairment Loss 87.07%-7.03M93.05%-3.44M98.15%-93.68K-142.09%-58.04M-534.05%-54.33M-267.39%-49.42M44.50%-5.06M-35.95%-23.97M-31.55%-8.57M-117.01%-13.45M
Other net revenue 121.78%12.93M153.63%23.53M194.88%3.36M-110.55%-58.05M-222.89%-59.34M-253.14%-43.87M82.56%-3.55M-313.01%-27.57M-2,625.03%-18.38M-77.15%-12.42M
Fair value change income 43.68%-8.67M74.48%-2.22M78.08%-1.58M22.27%-7.08M-12.66%-15.39M-856.58%-8.7M---7.22M---9.1M---13.66M---909.8K
Invest income -65.80%3.39M-66.51%2.65M-51.15%1.85M-29.25%8.59M-21.22%9.92M30.42%7.9M--3.79M2,974.97%12.15M2,539.81%12.59M1,274.20%6.06M
-Including: Investment income associates ----------0-87.86%42.22K-54.90%202.21K-10.90%202.21K--138.32K-11.92%347.88K186.87%448.36K143.97%226.96K
Asset deal income -84.03%-5.8M-22.66%-3.43M-258.71%-1.38M-1.13%-4.17M6.14%-3.15M-0.15%-2.8M-100.06%-386.04K-1.74%-4.12M-185.49%-3.36M-404.96%-2.79M
Other revenue -3.18%21.96M47.10%15.92M42.86%9.44M23.17%39.01M49.69%22.68M0.36%10.82M196.88%6.61M-27.80%31.67M4.62%15.15M6.58%10.79M
Operating profit 4.08%318.54M18.91%224.04M-2.75%136.45M-59.49%331.14M-55.29%306.05M-60.07%188.41M-43.99%140.31M-32.67%817.39M-32.68%684.47M-30.23%471.83M
Add:Non operating Income 333.08%1.41M919.61%1.37M31.79%73.57K-5.41%378.13K-4.95%326.02K196.18%134.75K420.57%55.82K-28.51%399.73K31.02%343.01K-65.61%45.49K
Less:Non operating expense -19.47%8.67M-62.33%2.27M-89.95%535.22K-8.91%26.15M-20.71%10.77M28.69%6.04M192.72%5.32M4.41%28.71M356.79%13.58M126.86%4.69M
Total profit 5.30%311.28M22.26%223.14M0.70%135.98M-61.30%305.37M-55.96%295.6M-60.93%182.51M-45.71%135.04M-33.53%789.08M-33.80%671.23M-30.72%467.18M
Less:Income tax cost 2.23%28.19M91.53%20.65M-31.81%11.74M-99.21%689.9K-61.09%27.57M-81.15%10.78M-52.88%17.22M-52.74%87.38M-60.84%70.86M-51.23%57.2M
Net profit 5.62%283.1M17.91%202.49M5.45%124.24M-56.58%304.68M-55.36%268.03M-58.11%171.73M-44.47%117.83M-29.99%701.71M-27.93%600.37M-26.40%409.98M
Net profit from continuing operation 5.62%283.1M17.91%202.49M5.45%124.24M-56.58%304.68M-55.36%268.03M-58.11%171.73M-44.47%117.83M-29.99%701.71M-27.93%600.37M-26.40%409.98M
Less:Minority Profit 367.30%1.72M124.57%764.15K299.05%3.8M-22.61%-7.94M-147.77%-645.21K-173.86%-3.11M-90.79%952.67K-114.19%-6.48M-100.70%-260.41K-83.41%4.21M
Net profit of parent company owners 4.72%281.37M15.38%201.73M3.05%120.44M-55.86%312.62M-55.27%268.68M-56.91%174.84M-42.10%116.87M-25.97%708.18M-24.56%600.64M-23.68%405.77M
Earning per share
Basic earning per share 5.65%0.463516.29%0.3325.26%0.2-56.20%0.5136-55.72%0.4387-57.57%0.2855-44.10%0.19-32.25%1.1726-30.85%0.9907-29.65%0.6728
Diluted earning per share 4.72%0.459415.38%0.32945.26%0.2-56.19%0.5104-55.72%0.4387-57.57%0.2855-44.10%0.19-32.18%1.1651-30.70%0.9907-29.53%0.6728
Other composite income 46.52%-9.04M86.27%-1.25M95.64%-363.65K-152.74%-8.4M-215.51%-16.91M-129.41%-9.12M-8.33M472.55%15.93M14.64M31.03M
Other composite income of parent company owners 46.52%-9.04M86.27%-1.25M95.64%-363.65K-152.74%-8.4M-215.51%-16.91M-129.41%-9.12M---8.33M472.55%15.93M--14.64M--31.03M
Total composite income 9.13%274.05M23.76%201.24M13.14%123.88M-58.71%296.28M-59.17%251.12M-63.13%162.6M-48.40%109.49M-28.09%717.63M-26.18%615.01M-20.83%441.01M
Total composite income of parent company owners 8.17%272.33M20.98%200.47M10.63%120.08M-57.99%304.22M-59.08%251.77M-62.06%165.71M-46.23%108.54M-23.96%724.11M-22.72%615.27M-17.85%436.8M
Total composite income of minority owners 367.30%1.72M124.57%764.15K299.05%3.8M-22.61%-7.94M-147.77%-645.21K-173.86%-3.11M-90.79%952.67K-114.19%-6.48M-100.70%-260.41K-83.41%4.21M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.